Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease

A.J. Lewthwaite, T.D. Lambert, E.B. Rolfe, S. Olgiati, M. Quadri, E.J. Simons, K.E. Morrison, V. Bonifati, D.J. Nicholl

Research output: Contribution to journalArticle

18 Citations (Scopus)


Background GTP cyclohydrolase I (GCH1) mutations are the commonest cause of Dopa-responsive dystonia (DRD). Clinical phenotypes can be broad, even within a single family. Methods We present clinical, genetic and functional imaging data on a British kindred in which affected subjects display phenotypes ranging from DRD to Parkinson's disease (PD). Twelve family members were studied. Clinical examination, dopamine transporter (DAT) imaging, and molecular genetic analysis of GCH1 and the commonest known familial PD-related genes were performed. Results We have identified a novel missense variant, c.5A > G, p.(Glu2Gly), within the GCH1 gene in affected family members displaying a range of phenotypes. Two affected subjects carrying this variant had abnormal DAT imaging. These two with abnormal DAT imaging had a PD phenotype, while the remaining three subjects with the novel GCH1 variant had normal DAT imaging and a DRD phenotype. Conclusions We propose that this GCH1 variant is pathogenic in this family and these findings suggest that similar mechanisms involving abnormal GTP cyclohydolase I may underlie both PD and DRD. GCH1 genetic testing should be considered in patients with PD and a family history of DRD.
Original languageEnglish
Pages (from-to)394-397
JournalParkinsonism and Related Disorders
Issue number4
Publication statusPublished - 26 Jan 2015

Fingerprint Dive into the research topics of 'Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease'. Together they form a unique fingerprint.

  • Cite this

    Lewthwaite, A. J., Lambert, T. D., Rolfe, E. B., Olgiati, S., Quadri, M., Simons, E. J., Morrison, K. E., Bonifati, V., & Nicholl, D. J. (2015). Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease. Parkinsonism and Related Disorders, 21(4), 394-397.